Kramsach, Austria

Dirk Classen-Houben

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Classen-Houben: Innovator in Viral Disease Treatment

Introduction

Dirk Classen-Houben is a notable inventor based in Kramsach, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.

Latest Patents

Dirk Classen-Houben holds 1 patent for his invention titled "7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease." This patent describes a compound with a general formula (A), which may exist in various forms such as pharmaceutically acceptable salts, solvates, polymorphs, codrugs, cocrystals, prodrugs, tautomers, racemates, enantiomers, or diastereomers. The compound is designed to be effective in treating, ameliorating, or preventing viral diseases, and it also discloses specific combination therapies.

Career Highlights

Throughout his career, Dirk has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Savira Pharmaceuticals GmbH and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Dirk has collaborated with several professionals in his field, including Andrea Wolkerstorfer and Oliver Szolar. These partnerships have likely enhanced his research and development efforts, leading to advancements in his work.

Conclusion

Dirk Classen-Houben is a distinguished inventor whose work in viral disease treatment showcases his innovative spirit and dedication to improving healthcare. His contributions through patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…